| | Identification | Back Directory |  | [Name] 
 Levofloxacin N-oxide
 |  | [CAS] 
 117678-38-3
 |  | [Synonyms] 
 Levofloxacin-3
 (S)-4-(6-carboxy-9
 Levofloxacin N-oxide
 Levofloacin Impurity 2
 Levofloxacin N-Oxide 1
 levofloxacin N-oxide832
 Levofloxacin BP Impurity C
 Levofloxacin nitrogen oxide
 USP Levofloxacin Related Compound C
 Levofloxacin Impurity C(Levofloxacin N-oxide)
 Levofloxacin N-Oxide(Levofloxacin EP Impurity C)
 Levofloxacin EP Impurity C (Levofloxacin N-Oxide)
 Levofloxacin impurity 7/Levofloxacin N-oxide/Levofloxacin EP Impurity C
 (S)-4-(6-carboxy-9-fluoro-3-methyl-7-oxo-2,3-dihydro-7H-[1,4]oxazino[2,3,4-ij]quinolin-10-yl)-1-methylpiperazine 1-oxide
 (S)-4-(6-carboxy-9-fluoro-3-methyl-7-oxo-3,7-dihydro-2H-[1,4]oxazino[2,3,4-ij]quinolin-10-yl)-1-methylpiperazine 1-oxide
 1-Methyl-4-[(9-fluoro-2,3-dihydro-6-carboxy-3α-methyl-7-oxo-7H-pyrido[1,2,3-de]-1,4-benzoxazin)-10-yl]piperazine 1-oxide
 7H-Pyrido[1,2,3-de]-1,4-benzoxazine-6-carboxylic acid, 9-fluoro-2,3-dihydro-3-methyl-10-(4-methyl-4-oxido-1-piperazinyl)-7-oxo-, (3S)-
 (S)-4-(6-Carboxy-9-fluoro-3-methyl-7-oxo-2,3-dihydro-7H-[1,4]oxazino[2,3,4-ij]quinolin-10-yl)-1-methylpiperazine 1-oxide (Levofloxacin N-Oxide)
 Levofloxacin N-oxideQ: What is 
Levofloxacin N-oxide Q: What is the CAS Number of 
Levofloxacin N-oxide Q: What is the storage condition of 
Levofloxacin N-oxide
 |  | [Molecular Formula] 
 C18H20FN3O5
 |  | [MDL Number] 
 MFCD24386420
 |  | [MOL File] 
 117678-38-3.mol
 |  | [Molecular Weight] 
 377.367
 | 
 | Chemical Properties | Back Directory |  | [Melting point ] 
 >146°C (dec.)
 |  | [storage temp. ] 
 Hygroscopic, -20°C Freezer, Under inert atmosphere
 |  | [solubility ] 
 Aqueous Base (Slightly), DMSO (Slightly), Methanol (Slightly, Sonicated)
 |  | [form ] 
 Solid
 |  | [pka] 
 5.19±0.40(Predicted)
 |  | [color ] 
 Off-White to Pale Green
 |  | [Stability:] 
 Hygroscopic
 |  | [InChI] 
 InChI=1S/C18H20FN3O5/c1-10-9-27-17-14-11(16(23)12(18(24)25)8-21(10)14)7-13(19)15(17)20-3-5-22(2,26)6-4-20/h7-8,10H,3-6,9H2,1-2H3,(H,24,25)/t10-/m0/s1
 |  | [InChIKey] 
 MVLAUMUQGRQERL-JTQLQIEISA-N
 |  | [SMILES] 
 O1C2=C(N3CC[N+]([O-])(C)CC3)C(F)=CC3C(=O)C(C(O)=O)=CN(C2=3)[C@@H](C)C1
 | 
 | Hazard Information | Back Directory |  | [Description] 
 Levofloxacin N-oxide is an inactive metabolite of the antibiotic levofloxacin . Levofloxacin N-oxide is also a degradation product of levofloxacin that is formed through exposure to daylight or hydrogen peroxide.
 |  | [Uses] 
 Levofloxacin N-oxide is an impurity of Ofloxacin (O245750), which is a fluorinated quinolone antibacterial.
 |  | [References] 
 [1] A HEMERYCK. Pharmacokinetics, metabolism, excretion and plasma protein binding of 14C-levofloxacin after a single oral administration in the Rhesus monkey.[J]. Xenobiotica, 2006, 36 7: 597-613. DOI: 10.1080/00498250600674436
 [2] Levofloxacin[J]. Reactions Weekly, 2018, 17 1: 232. DOI: 10.1007/s40278-018-53210-y
 [3] ANDRZEJ CZYRSKI   Artur T  Katarzyna Anusiak. The degradation of levofloxacin in infusions exposed to daylight with an identification of a degradation product with HPLC-MS.[J]. Scientific Reports, 2019: 3621. DOI: 10.1038/s41598-019-40201-9
 [4] M. LALITHA DEVI    K. B C. A validated stability-indicating RP-HPLC method for levofloxacin in the presence of degradation products, its process related impurities and identification of oxidative degradant[J]. Journal of pharmaceutical and biomedical analysis, 2009, 50 5: Pages 710-717. DOI: 10.1016/j.jpba.2009.05.038
 | 
 |  |